HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of effect of spironolactone on hair shaft diameter in hirsute females.

Abstract
Because of its anti-androgenic activity spironolactone 50-200 mg daily is advocated widely for the management of female hirsutism but this practice lacks adequately controlled experimental support. In a double-blind placebo controlled study of the efficacy of spironolactone 100 mg daily in idiopathic hirsutism we were unable to demonstrate objective benefit from spironolactone treatment. The mean effect of spironolactone given over a 9 month period was to increase hair shaft diameter by +15% with 95% CI (-0.4% to +29%). In addition there were no changes in circulating serum androgen concentrations.
AuthorsA R McLellan, J Rentoul, R MacKie, G T McInnes
JournalPostgraduate medical journal (Postgrad Med J) Vol. 65 Issue 765 Pg. 459-62 (Jul 1989) ISSN: 0032-5473 [Print] England
PMID2690044 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Androgens
  • Gonadotropins, Pituitary
  • Spironolactone
  • Canrenone
  • Prolactin
Topics
  • Androgens (blood)
  • Canrenone (blood)
  • Double-Blind Method
  • Female
  • Gonadotropins, Pituitary (blood)
  • Hair (anatomy & histology, drug effects)
  • Hirsutism (drug therapy)
  • Humans
  • Prolactin (blood)
  • Randomized Controlled Trials as Topic
  • Spironolactone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: